- 询价
- Miltenyi Biotec
- 德国
- 130-128-288
- 2025年12月09日
- Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- human cell line
- human
企业认证
相关产品推荐更多 >
CD268 Antibody, anti-human, VioBlue®, 100 tests in 1 mL
询价
CD10 Antibody, anti-human, pure, 100 µg in 100 µL
询价
CD29 Antibody, anti-human, PE-Vio® 615, REAfinity™, 100 tests in 200 µL
询价TNF-α Antibody, anti-human, FITC, 100 tests in 200 µL
询价CD312 (EMR2) Antibody, anti-human, APC, REAfinity™, 30 tests in 60 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
CD200
- 亚型：
recombinant human IgG1
- 形态：
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件：
避光，4-8℃
- 克隆性：
REA1067
- 标记物：
Vio Bright V423
- 适应物种：
human
- 保质期：
24个月
- 供应商：
Miltenyi Biotec
- 宿主：
human cell line
- 应用范围：
Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- 浓度：
1:50
- 抗体英文名：
CD200 Antibody, anti-human, REAfinity™
- 抗体名：
CD200 Antibody, anti-human, REAfinity™
- 规格：
30 tests in 60 µL
Identification and enumeration of CD200+ cells by flow cytometryClone REA1067 recognizes the human CD200 antigen, also known as MRC, MOX1/2, or OX-2, a type 1 membrane glycoprotein, which contains two immunoglobulin domains. Studies of the related gene in mouse and rat suggest that CD200 may regulate myeloid cell activity and delivers an inhibitory signal for the macrophage lineage in diverse tissues. CD200 may serve as a cancer stem cell marker as co-expression with other reported stem cell markers was found on prostate, breast, brain, and colon cancers. In addition, CD200 expression was shown to be a prognostic factor in AML and multiple myeloma. | Additional information: Clone REA1067 displays negligible binding to Fc receptors.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Minas, K. et al. (2006) Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal? Crit. Rev. Immunol. 26: 213–230. | Kawasaki, B. T. et al. (2007) Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells. Biochem. Biophys. Res. Commun. 364: 778–782. | Moreaux, J. et al. (2007) CD200 as a prognostic factor in acute myeloid leukemia. Blood 108: 4194–4197. | Tonks, A. et al. (2007) CD200 as a prognostic factor in acute myeloid leukemia. Leukemia 21: 566–568.
技术资料暂无技术资料 索取技术资料
文献支持
CD200 Antibody, anti-human, Vio® Bright V423, REAfinity™, 30 tests in 60 µL
询价
